Abstract
PurposeVoclosporin is a novel calcineurin inhibitor approved in the United States in January 2021 for the treatment of adult patients with active lupus nephritis in combination with background immunosuppressive therapy....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have